Welcome to our dedicated page for Neuberger Berman High Yield Strategies SEC filings (Ticker: NHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) filings page on Stock Titan is designed to organize the Fund’s regulatory information in one place, even though no specific SEC filings are listed in the current data set. As a diversified, closed-end management investment company focused on the high yield debt securities market, the Fund’s regulatory documents typically explain its investment policies, use of leverage, distribution practices and risk disclosures in more detail than brief news releases.
While the recent information available comes from press releases rather than SEC forms, those announcements reference key topics that are often discussed in formal filings, such as the Fund’s use of leverage through instruments like Mandatory Redeemable Preferred Shares and Floating Rate Senior Notes, its level distribution policy and its compliance with Section 19 of the Investment Company Act of 1940, as amended. They also include standard language noting that forward-looking statements involve risks and uncertainties related to market conditions, competition, regulation and operational factors.
On Stock Titan, when NHS regulatory filings are available from EDGAR, users can access documents such as annual and semi-annual reports or other required filings and use AI-powered tools to help interpret the information. These tools can highlight how the Fund describes its high yield debt strategy, leverage, distribution sources and risk factors, complementing what is already communicated through press releases about distributions, tender offers and leverage adjustments.
Investors interested in the Fund’s structure and policies can use this page to review its historical and future filings as they are added, alongside AI-generated explanations that summarize complex sections into more accessible language.
Neuberger High Yield Strategies Fund Inc. received an updated ownership report on its common shares from First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation. The group reports beneficial ownership of 5,725,238 shares, representing 22.08% of the fund’s common stock.
The reporting persons have no sole or shared voting power over these shares but report shared dispositive power over all 5,725,238 shares. The position largely reflects holdings in unit investment trusts sponsored by First Trust Portfolios L.P., plus other investment vehicles and accounts advised by First Trust Advisors L.P.
The filing states that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the fund. Each reporting entity disclaims beneficial ownership of the shares identified.
Neuberger High Yield Strategies Fund Inc. received an initial insider ownership report from portfolio manager Steven Richard Ruh. The Form 3 states that, as of 12/31/2025, no securities of the fund are beneficially owned. The filing is administrative in nature and does not report any purchases, sales, or derivative positions.
Neuberger High Yield Strategies Fund Inc. (NHS) reported a strong year for the 12 months ended October 31, 2025. The closed-end fund delivered a 9.03% total return on a net asset value (NAV) basis, outperforming its benchmark, the ICE BofA U.S. High Yield Constrained Index, which returned 8.03%. On a market price basis, the Fund returned 5.76% over the same period.
The Fund seeks high total return by investing primarily in high yield (below-investment-grade) debt, with a portfolio heavily concentrated in U.S. corporate bonds across sectors such as pipelines, commercial services, insurance, entertainment and energy. U.S. investments represented 118.7% of net assets, reflecting the impact of leverage.
Net assets applicable to common stockholders were $233.3 million, with 31,348,719 common shares outstanding and a NAV of $7.44 per share. The Fund paid $1.09 per share in distributions to common stockholders during the year, of which $0.58 per share is expected to be treated as return of capital for tax purposes. A stable monthly distribution of $0.0905 per share was in place at period end.
The Fund employs financial leverage through a $61.0 million secured revolving credit facility and $40.0 million of Mandatory Redeemable Preferred Shares, Series D, which can amplify both income and volatility. Management highlights ongoing focus on bottom-up credit research and issuer fundamentals while acknowledging risks from economic, rate, inflation and credit conditions.
Neuberger Berman High Yield Strategies Fund Inc. (NHS) received an amended Schedule 13G filing (Amendment No. 9) from First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation disclosing beneficial ownership of 5,463,038 common shares, representing 21.07% of the class, as of 09/30/2025.
The filing lists 0 shares with sole voting power and 0 shares with shared voting power, and 5,463,038 shares with shared dispositive power. The shares are held primarily across unit investment trusts and accounts associated with First Trust; voting for UIT-held shares is conducted by the trustee to mirror unaffiliated holders. The reporting persons state the position is held in the ordinary course of business and not for the purpose of changing or influencing control, and they disclaim beneficial ownership.
Form 4 highlights: On 07/17/2025, portfolio manager Chris Kocinski purchased 6,000 common shares of Neuberger Berman High Yield Strategies Fund Inc. (NHS) at a volume-weighted average price of $7.3995 (price range $7.395-$7.41). This was an open-market “P” code transaction and no shares were sold.
Following the trade, Kocinski’s direct beneficial ownership rose to 21,000 shares. No derivative securities were involved and there were no amendments to prior filings. The transaction suggests incremental insider confidence but represents a modest dollar amount (~$44k) relative to the fund’s market capitalization.